BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

199 related articles for article (PubMed ID: 18541728)

  • 1. Impact of nucleoside reverse transcriptase inhibitors on mitochondrial DNA and RNA in human skeletal muscle cells.
    Saitoh A; Haas RH; Naviaux RK; Salva NG; Wong JK; Spector SA
    Antimicrob Agents Chemother; 2008 Aug; 52(8):2825-30. PubMed ID: 18541728
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Vitamin D attenuates nucleoside reverse transcriptase inhibitor induced human skeletal muscle mitochondria DNA depletion.
    Campbell GR; Pallack ZT; Spector SA
    AIDS; 2013 Jun; 27(9):1397-401. PubMed ID: 23435299
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Impact of nucleoside reverse transcriptase inhibitors on mitochondria in human immunodeficiency virus type 1-infected children receiving highly active antiretroviral therapy.
    Saitoh A; Fenton T; Alvero C; Fletcher CV; Spector SA
    Antimicrob Agents Chemother; 2007 Dec; 51(12):4236-42. PubMed ID: 17893156
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Long-term exposure of mice to nucleoside analogues disrupts mitochondrial DNA maintenance in cortical neurons.
    Zhang Y; Song F; Gao Z; Ding W; Qiao L; Yang S; Chen X; Jin R; Chen D
    PLoS One; 2014; 9(1):e85637. PubMed ID: 24465628
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Longitudinal effects of thymidine analogues on mtDNA, mtRNA and multidrug resistance (MDR-1) induction in cultured cells.
    Papp E; Gadawski I; Côté HC
    J Antimicrob Chemother; 2008 May; 61(5):1048-52. PubMed ID: 18310046
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antiretroviral nucleosides, deoxynucleotide carrier and mitochondrial DNA: evidence supporting the DNA pol gamma hypothesis.
    Lewis W; Kohler JJ; Hosseini SH; Haase CP; Copeland WC; Bienstock RJ; Ludaway T; McNaught J; Russ R; Stuart T; Santoianni R
    AIDS; 2006 Mar; 20(5):675-84. PubMed ID: 16514297
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mitochondrial DNA and RNA increase in peripheral blood mononuclear cells from HIV-1-infected patients randomized to receive stavudine-containing or stavudine-sparing combination therapy.
    Casula M; Weverling GJ; Wit FW; Timmermans EC; Stek M; Lange JM; Reiss P
    J Infect Dis; 2005 Nov; 192(10):1794-800. PubMed ID: 16235179
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Assessment of mitochondrial toxicity in human cells treated with tenofovir: comparison with other nucleoside reverse transcriptase inhibitors.
    Birkus G; Hitchcock MJ; Cihlar T
    Antimicrob Agents Chemother; 2002 Mar; 46(3):716-23. PubMed ID: 11850253
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Relationship of mitochondrial DNA depletion and respiratory chain activity in preadipocytes treated with nucleoside reverse transcriptase inhibitors.
    Stankov MV; Lücke T; Das AM; Schmidt RE; Behrens GM;
    Antivir Ther; 2007; 12(2):205-16. PubMed ID: 17503663
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The M184V mutation in HIV-1 reverse transcriptase (RT) conferring lamivudine resistance does not result in broad cross-resistance to nucleoside analogue RT inhibitors.
    Miller V; Stürmer M; Staszewski S; Gröschel B; Hertogs K; de Béthune MP; Pauwels R; Harrigan PR; Bloor S; Kemp SD; Larder BA
    AIDS; 1998 May; 12(7):705-12. PubMed ID: 9619801
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The HIV-1 nucleoside reverse transcriptase inhibitors stavudine and zidovudine alter adipocyte functions in vitro.
    Caron M; Auclair M; Lagathu C; Lombès A; Walker UA; Kornprobst M; Capeau J
    AIDS; 2004 Nov; 18(16):2127-36. PubMed ID: 15577645
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mitochondrial toxicity of tenofovir, emtricitabine and abacavir alone and in combination with additional nucleoside reverse transcriptase inhibitors.
    Venhoff N; Setzer B; Melkaoui K; Walker UA
    Antivir Ther; 2007; 12(7):1075-85. PubMed ID: 18018766
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Transplacentally exposed human and monkey newborn infants show similar evidence of nucleoside reverse transcriptase inhibitor-induced mitochondrial toxicity.
    Divi RL; Leonard SL; Kuo MM; Nagashima K; Thamire C; St Claire MC; Wade NA; Walker VE; Poirier MC
    Environ Mol Mutagen; 2007; 48(3-4):201-9. PubMed ID: 16538687
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In vivo, nucleoside reverse-transcriptase inhibitors alter expression of both mitochondrial and lipid metabolism genes in the absence of depletion of mitochondrial DNA.
    Mallon PW; Unemori P; Sedwell R; Morey A; Rafferty M; Williams K; Chisholm D; Samaras K; Emery S; Kelleher A; Cooper DA; Carr A;
    J Infect Dis; 2005 May; 191(10):1686-96. PubMed ID: 15838796
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mitochondrial (mt)DNA changes in tissue may not be reflected by depletion of mtDNA in peripheral blood mononuclear cells in HIV-infected patients.
    Maagaard A; Holberg-Petersen M; Kollberg G; Oldfors A; Sandvik L; Bruun JN
    Antivir Ther; 2006; 11(5):601-8. PubMed ID: 16964828
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Erythrocebus patas monkey offspring exposed perinatally to NRTIs sustain skeletal muscle mitochondrial compromise at birth and at 1 year of age.
    Divi RL; Leonard SL; Walker BL; Kuo MM; Shockley ME; St Claire MC; Nagashima K; Harbaugh SW; Harbaugh JW; Poirier MC
    Toxicol Sci; 2007 Sep; 99(1):203-13. PubMed ID: 17545213
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evaluation of antiretroviral drug efficacy for HIV-1 encephalitis in SCID mice.
    Limoges J; Persidsky Y; Poluektova L; Rasmussen J; Ratanasuwan W; Zelivyanskaya M; McClernon DR; Lanier ER; Gendelman HE
    Neurology; 2000 Jan; 54(2):379-89. PubMed ID: 10668699
    [TBL] [Abstract][Full Text] [Related]  

  • 18. BMS-986001, an HIV nucleoside reverse transcriptase inhibitor, does not degrade mitochondrial DNA in long-term primary cultures of cells isolated from human kidney, muscle, and adipose tissue.
    Wang F; Flint OP
    Antimicrob Agents Chemother; 2013 Dec; 57(12):6205-12. PubMed ID: 24080659
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mitochondrial and metabolic effects of nucleoside reverse transcriptase inhibitors (NRTIs) in mice receiving one of five single- and three dual-NRTI treatments.
    Note R; Maisonneuve C; Lettéron P; Peytavin G; Djouadi F; Igoudjil A; Guimont MC; Biour M; Pessayre D; Fromenty B
    Antimicrob Agents Chemother; 2003 Nov; 47(11):3384-92. PubMed ID: 14576092
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Progressive mitochondrial compromise in brains and livers of primates exposed in utero to nucleoside reverse transcriptase inhibitors (NRTIs).
    Divi RL; Einem TL; Fletcher SL; Shockley ME; Kuo MM; St Claire MC; Cook A; Nagashima K; Harbaugh SW; Harbaugh JW; Poirier MC
    Toxicol Sci; 2010 Nov; 118(1):191-201. PubMed ID: 20702595
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.